Therapeutic use of colchicine and its derivatives: a patent review

References

• Rodnan GP, Benedek TG. The early history of antirheumatic drugs. Arthritis Rheum. 1970;13(2):145–165.
   PubMed Web of Science ®Google Scholar
• Nuki G, Simkin PA. A concise history of gout and hyperuricemia and their treatment. Arthritis Res Ther. 2006;8(Suppl 1):S1. Epub 2006 Apr 12.
   PubMed Web of Science ®Google Scholar
• Gritzalis KC, Karamanou M, Androutsos G. Gout in the writings of eminent Ancient Greek and byzantine physicians. Acta Med-Hist Adriat. 2011;9(1):83–88.
   PubMedGoogle Scholar
• Horn JR, Hansten PD. Life-threatening colchicine drug interactions [Internet]. [ Cited 2015 Mar 12]. Available from: http://www.hanstenandhorn.com/hh-article05-06.pdf.
   Google Scholar
• Balasubramanian E, Gajendran T. Comparative studies on the anticancer activity of colchicine by various controlled drug delivery modes. Int J Pharm Bio Sci. 2013;4:9–26.
   Google Scholar
• Sivakumar G. Colchicine semi-synthetics: chemotherapeutics for cancer? Curr Med Chem. 2013;20(7):892–898.
   PubMed Web of Science ®Google Scholar
• Larsson S, Ronsted N. Reviewing colchicaceae alkaloids - perspectives of evolution on medicinal chemistry. Curr Top Med Chem. 2014;14(2):274–289.
   PubMed Web of Science ®Google Scholar
• Univ Kunming Science & Tech. Preparation method for colchicine. CN102627576A. 2014.
   Google Scholar
• Suzhou Paiteng Biopharmaceutic Co Ltd. Preparation method of colchicumautumnale. CN101602686A. 2011.
   Google Scholar
• Metabolex Inc, Saha GC, Lavan BE, et al. Method for treating hyperuricemia in patients with gout using halofenate or halofenic acid and an anti-inflammatory agent. WO2013155478A1. 2013.
   Google Scholar
• Ardea Biosciences Inc, Miner J, Girardet J, et al. Treatment of gout. US2013059868A1. 2013.
   Google Scholar
• Pfizer Ltd. New salt and medical use. WO2013057722A1. 2013.
   Google Scholar
• Twi Biotechnology Inc, Ku MS, Chen CK, et al. Method and compositions for treating hyperuricemia and metabolic disorders associated with hyperuricemia. US2012232044A1. 2012.
   Google Scholar
• Baylor College Medicine. Small molecule xanthine oxidase inhibitors and methods of use. US2014378478A1. 2014.
   Google Scholar
• Ardea Biosciences Inc, De La Rosa M, Girardet J, et al. Methods of modulating uric acid levels. US8372807B2. 2013.
   Google Scholar
• Ardea Biosciences Inc, De La Rosa M, Girardet J. Compounds, Compositions and Methods for Modulating Uric Acid Levels. US2012122780A1. 2012.
   Google Scholar
• Nuon Therapeutics Inc. Combination formulations of tranilast and allopurinol and methods thereto. US2011136835A1. 2011.
   Google Scholar
• Xoma US LLC. Methods for treatment of gout. US2014370002A1. 2014.
   Google Scholar
• Kissei Pharm Co Ltd. (Aza) indole derivative and use thereof for medical purposes. US8993616B2. 2015.
   Google Scholar
• Kotobuki Pharm Co Ltd, Tomiyama H, Tokuzaki K, et al. Substituted amine derivative and medicinal composition comprising same as the active ingredient. WO2010027005A1. 2010.
   Google Scholar
• Regeneron Pharm Inc. Human antibodies to NAV1.7. WO2014159595. 2014.
   Google Scholar
• Glaxosmithkline Llc, Nunez D. Treatment of Blood Lipid Abnormalities and Other Conditions. WO2011150067A1. 2011.
   Google Scholar
• Hadasit Medical Res Services & Dev Ltd. Use of copolymer 1 for treatment of muscular dystrophy. US8193147B2. 2012.
   Google Scholar
• Chiang PK. Methods and compositions for treating diseases associated with pathogenic proteins. US2013005650A1. 2013.
   Google Scholar
• Regeneron Pharm Inc. Use of protease-activated receptor 2 (PAR2) antagonist. TW201002345A. 2010.
   Google Scholar
• Lee E, Young PP. Pyrvinium wound treatment methods and devices. US2012318262A1. 2012.
   Google Scholar
• Mestex AG. Mixture of a vanilloid receptor agonist and a substance inhibiting nerve-regeneration, use thereof for producing a painkiller, and method for applying said Painkiller. US2010047181A1. 2010.
   Google Scholar
• Moy L. Novel treatments for actinic keratoses. US2014256667A1. 2014.
   Google Scholar
• Univ. Ramot At Tel Aviv Ltd. Treatment of neurofibromatosis. US2011046223A1. 2011.
   Google Scholar
• Univ. California. Methods of modulating compliance of the trabecular meshwork. US2014187607A1. 2014.
   Google Scholar
• Borody TJ, Ramrakha S, Saxon J, et al. Gastric and colonic formulations and methods for making and using them. WO2012079118A1. 2012.
   Google Scholar
• Borody TJ. Laxative composition and methods for treating constipation and related gastrointestinal diseases and conditions. WO2014032108A1. 2014.
   Google Scholar
• Shantha TR. Rabies cure. US2011020279A1. 2011.
   Google Scholar
• Activbiotics Pharma Llc, Sayada C. Adminsitration of Rifalazil to immune-compromised patients. WO2012011917A1. 2012.
   Google Scholar
• Lumena Pharm Inc. bile acid recycling inhibitors for treatment of hypercholemia and cholestatic liver disease. WO2013063526A1. 2013.
   Google Scholar
• Biogen Idec Ma Inc. Systemic administration of colony stimulating factors to treat amyloid associated disorders. US2010266528A1. 2010.
   Google Scholar
• Univ. California, Kisseleva T, Brenner D. Inducing Inactivation of Fibrogenic myofibroblasts. US2013101553A1. 2013.
   Google Scholar
• Consortium PIK LLC. Pharmaceutical composition of herbal docosahexaenoic acid for treating and preventing hepatic disorders. RU2011144780A. 2013.
   Google Scholar
• Daiichi Kokusai Kagi Kofun Y. Extract from saussurea involucrate, Food/Drink composition and basic cosmetic composition each containing the same. JP2011136969A. 2011.
   Google Scholar
• Univ. Tennessee Res Found. Substituted acylanildes and methods of use thereof. JP5345534B2. 2013.
   Google Scholar
• Univ. Brandeis and Univ Georgia Res Found Inc. Compound and Methods for Treating Mammalian Gastrointestinal Parasitic Infections. US2010022547A1. 2010.
   Google Scholar
• Reid CB. Compositions and formulations for preventing and treating chronic diseases that cluster in patients as cardiovascular disease, diabetes, obesity, polycystic ovary syndrome, hyperlipidemia and hypertension, as well as for preventing and treating other diseases and conditions. US2014271923A1. 2014.
   Google Scholar
• Cytokinetics Inc., Morgans DJ, Malik F, et al. Methods of Treating Lung Diseases. WO2012009097A1. 2012.
   Google Scholar
• Regeneron Pharm Inc. Methods of using IL-1 antagonists to treat autoinflammatory disease. AU2011224099A1. 2011.
   Google Scholar
• Comgenrx Inc., Oronsky BT, Oronsky NC. Combination therapy for bipolar disorder. US8138169B2. 2012.
   Google Scholar
• Moerae Matrix Inc., Lander C, Brophy C, et al. Compositions and methods for treating cutaneous scarring. WO2014040074A2. 2014.
   Google Scholar
• Takeda Pharm USA Inc., Davis M, Feng H. Colchicine composition and methods. US8415395B1. 2013.
   Google Scholar
• Takeda Pharmaceuticals USA Inc. Colchicine formulations methods of making and methods of use thereof. WO2013149109A1. 2013.
   Google Scholar
• Mutual Pharm Co Inc. Colchicine solid complex; methods of making; and methods of use thereof. US8003700B2. 2011.
   Google Scholar
• Wei X. Colchicine microemulsion transdermal agent, preparation method thereof and application thereof. CN102366403A. 2012.
   Google Scholar
• Shanghai Inst. Planned Parenthood Res, Shao H, Li Y, et al. Transdermal delivery ointment containing colchicine, and preparation method thereof. CN103251550A. 2013.
   Google Scholar
• Hsin-Yung Lin. A pharmaceutical composition inhaling type for the treatment of gout and preparation method thereof. DE102015104359. 2015.
   Google Scholar
• Nielsen KR, Manchanda R, Sun T, et al. Thiocolchicine and colchicine analogs, methods of making and methods of use thereof. US2011184061A1. 2011.
   Google Scholar
• Mutual Pharmaceutical Co. Deuterium-enriched colchicine, thiocolchicine, and derivatives thereof; methods of preparation and use thereof. US2011178180A1. 2011.
   Google Scholar
• Mutual Pharm Co Inc. Methods for concomitant administration of colchicine and a second active agent. US2011046227A1. 2011.
   Google Scholar
• Mutual Pharm Co Inc. Methods for administration of colchicine with grapefruit juice. US2011046228A1. 2011.
   Google Scholar
• Mutual Pharm Co Inc. Methods for concomitant administration of colchicine and macrolide antibiotics. US8097655B2. 2012.
   Google Scholar
• Mutual Pharm Co Inc, Davis MW. System and methods for pharmacy management of drugs. US2012065992A1. 2012.
   Google Scholar
• Takeda Pharm USA Inc, Davis MW. Methods for concomitant administration of colchicine and a second active agent. US2011275720A1. 2011.
   Google Scholar
• Takeda Pharm USA Inc and Teijin Pharm Ltd. Methods of treatment and composition with xanthine oxidase inhibitors. US2014357683A1. 2014.
   Google Scholar
• Hikma Pharm Llc. Methods of colchicine administration. US8927607B1. 2015.
   Google Scholar
• Revive Therapeutics Inc. The use of bucillamine in the treatment of gout. WO2014078956A1. 2014.
   Google Scholar
• Xinchang Dacheng Biotechnology Co Ltd. Drug composition containing Criofolinine and application thereof. CN104586856A. 2015.
   Google Scholar
• Xinchang Dacheng Biotechnology Co Ltd. Drug composition containing Vernavosine and application thereof. CN104586852A. 2015.
   Google Scholar
• Murray & Pool Enterprises Ltd. Sustained release formulation of Colchicine and Method of Using Same. WO2014170755A2. 2014.
   Google Scholar
• Heart Care Western Australia Pty Ltd., Nidorf M. Treatment or prevention of a cardiovascular event via the administration of colchicine derivatives. WO2014066944A1. 2014.
   Google Scholar
• London Biotech Ltd., Xu W. Screen compounds for the modulation of proprotein convertase subtilisin/kexin type 9(PCSK9). GB2523527A. 2015.
   Google Scholar
• Univ. Maryland Baltimore, Ward CW, Khairallah R. Treatment of muscular conditions and muscular dystrophies. WO2013078261A1. 2013.
   Google Scholar
• Alkaloids Corp. Preparing glycosylated colchicine e.g. colchicoside involves contacting colchicine with Bacillus aryabhattai in a suitable condition and isolating glycosylated colchicines. IN201306035I4. 2014.
   Google Scholar
• Elysian Life Sciences Private Ltd, Kanagavelrajan S, Prabakaran K, et al. Microbial method for the biotransformation of colchicinoid compounds. US2014024080A1. 2014.
   Google Scholar
• Borody TJ. Novel enteric combination therapy. US2014364373A1. 2012.
   Google Scholar
• Univ. Maryland Baltimore, Leggett SB, Wang WCH, et al. Methods of treating obstructive lung diseases using bitter tastants. WO2012021291A2. 2012.
   Google Scholar
• Univ. China Pharm. Application of colchicine in preparing cholestatic liver disease drug. CN101822659A. 2010.
   Google Scholar
• Marino BT, Marino JF. Compounds and Methods for Appetite Suppression and Weight Control. US2014141100A1. 2014.
   Google Scholar
• The Asan Foundation, Han DJ, Suh J, et al. Colchicine derivatives or pharmaceutically acceptable salts thereof, method for preparing said derivatives, and pharmaceutical composition comprising said derivatives. US2013011417A1. 2011.
   Google Scholar
• Univ. Texas, Andersson BS, Valdez BC, et al. Improved parenteral formulations of lipophilic pharmaceutical agents and methods for preparing and using the same. WO2012148799A1. 2012.
   Google Scholar
• Sharma A. Medicament and treatment for infections. WO2010020789A2. 2010.
   Google Scholar
• US Dept. Health & Human Services, Liang TJ, Li Q, et al. Methods of modulating hepatitis C virus infection. WO2011003071A1. 2011.
   Google Scholar
• Christopher MB, Robert LW. Latest evidence on gout management: what the clinician needs to know. Ther Adv Chronic Dis. 2012;3(6):271–286.
   PubMedGoogle Scholar
• Kydd AS, Seth R, Buchbinder R, et al. Urate-lowering therapy for the management of gout: a summary of 2 cochrane reviews. J Rheumatol Suppl. 2014;92:33–41.
   PubMedGoogle Scholar
• Morris I, Varughese G, Mattingly P. Colchicine in acute gout. BMJ. 2003;327(7426):1275–1276.
   PubMed Web of Science ®Google Scholar
• Moreland LW, Ball GV. Colchicine and gout. Arthritis Rheum. 1991;34(6):782–786.
   PubMed Web of Science ®Google Scholar
• van der Velden W, Huussen J, Ter Laak H, et al. Colchicine-induced neuromyopathy in a patient with chronic renal failure: the role of clarithromycin. Neth J Med. 2008;66(5):204–206.
   PubMed Web of Science ®Google Scholar
• Imaqzio M, Brucato A, Cemin R, et al. A randomized trial of colchicine for acute pericarditis. N Engl J Med. 2013;369:1522–1528.
   PubMed Web of Science ®Google Scholar
• Faloon WW, Webb D, Race TF. Cholesterol lowering effect of colchicine. Ann Intern Med. 1967;66:1058–1058.
   Web of Science ®Google Scholar
• Rubulis A, Rubert M, Faloon WW. Cholesterol lowering, fecal bile acid, and sterol changes during neomycin and colchicine. Am J Clin Nutr. 1970;23:1251–1259.
   PubMed Web of Science ®Google Scholar
• Executive Summary. Guidelines on the diagnosis and management of pericardial diseases. The task force on the diagnosis and management of pericardial diseases of the European society of cardiology. Euro Heart J. 2004;25(7):587–610.
   PubMed Web of Science ®Google Scholar
• Hufford CD, Collins CC, Clark AM. Microbial transformations and 13C-NMR analysis of colchicine. J Pharm Sci. 1979;68(10):1239–1242.
   PubMed Web of Science ®Google Scholar
• Li Y. Ointment for treating acute gout and preparation method thereof. CN10932106963A. 2011.
   Google Scholar
• Huang C. Drug for treating high uric acid. CN103463491A. 2013.
   Google Scholar
• Sang J. Tibetan medicine for treating gout. CN104189662A. 2014.
   Google Scholar
• Philadelphia Health & Education Corp. Methods for treating or preventing fibrosis in subjects afflicted with scleroderma. US2014314746A1. 2014.
   Google Scholar
• Varga J. Systemic sclerosis: an update. Bull NYU Hosp Jt Dis. 2008;66:198–202.
   PubMedGoogle Scholar
• Sichuan Acad. Chinese Med. Sci. Traditional Chinese medicine extract capable of resisting fibrosis and preparation method and application thereof. CN103751315A. 2014.
   Google Scholar
• Shanghai News and Press Bureau. Uygur Medicine [Internet]; 2007 [Cited 2016 Mar 6]. Available from: http://kaleidoscope.cultural-china.com/en/120Kaleidoscope6134.html.
   Google Scholar
• Maimaitiaili A. External uygur ointment useful for treating joint diseases. CN103230384A. 2013.
   Google Scholar
• Xinjiang Xiwang Pharm Co Ltd. Aqueous compound peganum harmala pharmaceutical composition and preparation method thereof. CN102961557A. 2013.
   Google Scholar
• Zhao L. Compound analgesic composition and preparation method thereof. CN102266563A. 2011.
   Google Scholar
• Xin H, Xin Y, Medicine for treating lumbar disc herniation and preparation method thereof. CN105055791A. 2015.
   Google Scholar
• Jinan Fangyu Culture and Media Co Ltd. Muscle relaxing and blood circulations activating composition for treating lumbar muscle strain and preparation method thereof. CN104644790A. 2015.
   Google Scholar
• Jinan Fangyu Culture and Media Co Ltd. Composition for treating back and leg pain and preparation method for composition. CN104606384A. 2015.
   Google Scholar
• Jinan Fangyu Culture and Media Co Ltd. Composition for treating cervical spondylosis and preparation method of composition. CN104623042A. 2015.
   Google Scholar
• Jinan Fangyu Culture and Media Co Ltd. Composition for treating hyperostosis and preparation method for composition. CN104606414A. 2015.
   Google Scholar
• Jinan Fangyu Culture and Media Co Ltd. Composition for treating pain caused by femoral head necrosis and preparation method for composition. CN104606413A. 2015.
   Google Scholar
• Dewar MJS. Structure of colchicine. Nature. 1945;155:141–142.
   Web of Science ®Google Scholar
• Banwell MG. Cyclopropyl compounds as chemical building blocks: total syntheses of the alkaloids (-)-colchicine, imerubrine and grandirubrine. Pure Appl Chem. 1996;68(3):539–542.
   Web of Science ®Google Scholar
• Chongqing Medical University Low-dose Colchicine in Patients with Type 2 Diabetes Mellitus and Microalbuminuria. NCT02035891. 2014.
   Google Scholar
• Sheba Medical Center. Colchicine for Diabetic Nephropathy. NCT01005121. 2009.
   Google Scholar
• Finkelstein Y, Aks SE, Hutson JR, et al. Colchicine poisoning: the dark side of an ancient drug. Clin Toxicol (Phila). 2010;48(5):407–414.
   PubMed Web of Science ®Google Scholar
• Global and China Colchicine Industry 2014 Market Research Report; 2014 [Cited 2016 Mar 12]. Available from: http://www.qyresearchreports.com/report/global-and-china-colchicine-industry-2014-market-research-report.htm.
   Google Scholar